Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Palestine Health Report.
Press releases published on October 31, 2025
Quantum BioPharma Ltd. Provides Corporate Update
TORONTO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K9A) (“Quantum” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to …
Teva to Present at UBS Global Healthcare Conference and Jefferies London Healthcare Conference in November
TEL AVIV, Israel, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at two upcoming investor conferences in November as follows: UBS …
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, on October 15, 2025, the Compensation Committee of the Board of Directors …
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MALVERN, Pa., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from …
Cellectis to Report Third Quarter Financial Results on November 7, 2025
NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced …
FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Advancing preparations to begin manufacturing of fibroblast-based spheroids product candidate, CYWC628, for the Phase 1/2 clinical trial evaluating CYWC628 in diabetic foot ulcers (DFU) patients Preparing to submit Investigational New Drug applications …
Edesa Biotech Announces Upcoming Conference Schedule
TORONTO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, announced today that Edesa management and business …
Organogenesis Holdings Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CANTON, Mass., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (the “Company”) (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound …
Clover Health Announces Chelsea Clinton to Step Down from Board Following Eight Years of Service
WILMINGTON, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) today announced that Chelsea Clinton, the longest-serving member of its Board of Directors, having joined the …
China’s DNA Sequencing Market to Grow at 21.5% CAGR by 2030
Boston, Oct. 31, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “The Chinese Market for DNA Sequencing” is projected to grow from $1.2 billion in 2025 to $3.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of …
Georgia Health Care Organizations Unite to Strengthen Rural and Statewide Senior Care
NORCROSS, Ga., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Georgia’s two largest post-acute care providers, Community Health Services of Georgia (CHSGa) and PruittHealth, today announced a strategic partnership designed to enhance care coordination and health …
Protext Mobility, Inc. (OTC: TXTM) Announces CEO Statement Following Removal of Caveat Emptor Designation
NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Protext Mobility, Inc. (OTC: TXTM) (“TXTM”), an emerging biotechnology company pioneering advancements in plant-based therapeutics, today released an official statement from Chief Executive Officer Mr. Dylon Du …
Cosmos Health Enters New Nanotechnology R&D Program to Develop Next-Generation Nutraceutical Formulas with Enhanced Phytochemical Efficacy
CHICAGO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the initiation of a new research and development program …
Spherix Global Insights Launches Market Dynamix™: PD-1 Inhibition in Solid Tumors, Delivering a Comprehensive Assessment of Biosimilar and Subcutaneous PD-1 Market Dynamics Across Key Oncology Indications
EXTON, PA, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Spherix Global Insights has announced the launch of its latest Market Dynamix™ service, PD-1 Inhibition in Solid Tumors (US) 2025, providing an in-depth analysis and advisory services for the evolving immuno- …
Test And Tren Cycle For Muscle Growth - CrazyBulk Lunch Test and Tren Stack (Tren Max) Pills for Bodybuilding, Beginners Dosage, Benefits, Before And After Results
NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- NEW YORK, Oct 20, 2025, Crazybulk launches Legal Alternatives to the Test and Tren Cycle for Beginners, Bulking, Bodybuilding, and Muscle growth, Cutting. In this article, we will be discussing (Test and Tren …
BioGrowing to Showcase Leadership as Probiotic Solution Provider with Top Journal Featured AKK Strains at SupplySide Global 2025
LAS VEGAS, Oct. 31, 2025 (GLOBE NEWSWIRE) -- BioGrowing, a global leader in probiotic research and manufacturing, and comprehensive probiotic solution provider, captivated industry attention at SupplySide Global 2025 with its revolutionary Akkermansia …
Behind the Bathroom Door: Urology Care Foundation Flushes Out Myths for Bladder Health Month
BALTIMORE, Oct. 31, 2025 (GLOBE NEWSWIRE) -- November is Bladder Health Month, and the Urology Care Foundation (UCF), the official foundation of the American Urological Association, is lifting the lid on bladder health—flushing out myths, streaming in …
PharmaJet® Signs Distribution Agreement with EVA Pharma to Provide Needle-free Injection Systems to Support Routine Polio Immunization in Egypt
GOLDEN, Colo. and CAIRO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- PharmaJet®, a company that strives to improve the performance and outcomes of injectables with its enabling needle-free injection technology, today announced that it has signed a Distribution …
Capricor Therapeutics to Present Third Quarter 2025 Financial Results and Recent Corporate Update on November 10
SAN DIEGO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that it will release its financial …